Fmoc-alpha-Octenyl-D-Ala-OH

Online Inquiry

CAT#CP25713
CAS288617-75-4
Synonyms/Alias288617-75-4;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldec-9-enoicacid;(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoicacid;Fmoc-2-(7'-octenyl)alanine;SCHEMBL15667695;MolPort-023-223-389;ZINC36914706;AKOS015918397;(S)-N-Fmoc-2-(7'-octenyl)alanine;CF-1385;DS-3079;AJ-93446;AK108353;AM007332;AN-29052;FT-0655469;ST51055709;I14-7727;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-2-methyl-dec-9-enoicacid;(2S)-2-(9H-Fluorene-9-ylmethoxycarbonylamino)-2-methyl-9-decenoicacid;(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-2-METHYLDEC-9-ENOICACID
Chemical Name(S)-2-(9-Fluorenylmethyloxycarbonyl)amino-2-methyldec-9-enoic acid (contains 10 to 40% MTBE)
M.F/FormulaC26H31NO4
M.W/Mr.421.53
ApplicationPeptide synthesis; Drug screening
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 BIO 1211, is a non-covalent, small-molecule, cyclohexanecarboxylic acid base compound, tight-binding inhibitor ( ...

  st-Ht31, a protein kinase A (PKA)-anchoring inhibitor, greatly induces robust cholesterol or phospholipid effl ...

Trimetazidine is a partial fatty acid oxidation inhibitor that inhibits 3-ketoacyl CoA thiolase, one of the enzymes of fatty ...

 Dalbavancin, marketed under the brand name of Dalvance, is a new semi-synthetic glycopeptide antibiotic for anti ...

  Perindopril erbumine is an angiotensioncon vertingenzyme (ACE) inhibitor without sulfhydryl group. It is a chi ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.